KHANNA PUSHPA has a total of 12 patent applications. Its first patent ever was published in 1974. It filed its patents most often in Australia, China and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and biotechnology are BIO LIFE SCIENCE FORSCHUNGS & ENTWICKLUNGSGESELLSCHAFT MBH, BRIM BIOTECHNOLOGY INC and CIDARA THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | China | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | South Africa | 2 | |
#5 | Canada | 1 | |
#6 | Germany | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Khanna Pushpa | 11 |
#2 | Khanna Pushpa Dr | 1 |
Publication | Filing date | Title |
---|---|---|
ZA200200111B | Novel oil from momordica charantia L. its method of preparation and uses. | |
ZA200108326B | Protein/polypeptide-k obtained from momordica charantia and a process for the extraction thereof. | |
AU1889400A | Protein/polypeptide-K obtained from momordica charantia and a process for the extraction thereof | |
US6964786B1 | Oil from Momordica charantia L., its method of preparation and uses | |
DE2432334A1 | Insulin from a plant source - by extraction of the fruit or seed cultures of Memordica charantia |